NASDAQ:VBIV - VBI Vaccines News Headlines

Sign in or create an account to add this stock to your watchlist.
$1.53 +0.13 (+9.29 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$1.53
Today's Range$1.40 - $1.54
52-Week Range$1.30 - $4.70
Volume1.29 million shs
Average Volume662,478 shs
Market Capitalization$90.14 million
P/E RatioN/A
Dividend YieldN/A
Beta2.02

Headlines

VBI Vaccines (NASDAQ VBIV) News Headlines

Source:
DateHeadline
VBI Vaccines Announces Pricing of $37.5 Million Public OfferingVBI Vaccines Announces Pricing of $37.5 Million Public Offering
finance.yahoo.com - December 13 at 5:13 PM
VBI Vaccines Announces Proposed Public Offering of Common SharesVBI Vaccines Announces Proposed Public Offering of Common Shares
finance.yahoo.com - December 12 at 5:04 PM
Form 8-K VBI Vaccines Inc/BC For: Dec 04 - StreetInsider.comForm 8-K VBI Vaccines Inc/BC For: Dec 04 - StreetInsider.com
www.streetinsider.com - December 6 at 9:07 AM
VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences for up to $129 Million plus Royalties to Develop a Functional Cure for Hepatitis BVBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences for up to $129 Million plus Royalties to Develop a Functional Cure for Hepatitis B
finance.yahoo.com - December 6 at 9:07 AM
VBI Vaccines Announces Third Quarter 2018 Financial Results and Provides Corporate UpdateVBI Vaccines Announces Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 9 at 9:34 AM
Research Report Identifies Sorrento Therapeutics, Hurco Companies, Veritiv, Park Electrochemical, VBI Vaccines, and ...Research Report Identifies Sorrento Therapeutics, Hurco Companies, Veritiv, Park Electrochemical, VBI Vaccines, and ...
globenewswire.com - October 25 at 4:45 PM
VBI Vaccines to Present Initial Data for VBI-1901 in Recurrent Glioblastoma (GBM) Patients at the 2018 Annual Meeting of the Society for Neuro-Oncology (SNO)VBI Vaccines to Present Initial Data for VBI-1901 in Recurrent Glioblastoma (GBM) Patients at the 2018 Annual Meeting of the Society for Neuro-Oncology (SNO)
finance.yahoo.com - October 24 at 8:47 AM
VBI Vaccines (VBIV) Reports Complete Vaccination in PROTECT Phase 3 Clinical Study for Sci-B-Vac Hepatitis B VaccineVBI Vaccines (VBIV) Reports Complete Vaccination in PROTECT Phase 3 Clinical Study for Sci-B-Vac Hepatitis B Vaccine
www.streetinsider.com - October 17 at 8:49 AM
Vaccinations completed in VBIs late-stage study for Sci-B-VacVaccinations completed in VBI's late-stage study for Sci-B-Vac
seekingalpha.com - October 16 at 4:40 PM
VBI Vaccines Completes Vaccination in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B VaccineVBI Vaccines Completes Vaccination in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B Vaccine
finance.yahoo.com - October 16 at 9:00 AM
VBI Vaccines (VBIV) Announces Late-Breaker Cytomegalovirus Abstract Chosen for Oral Presentation at IDWeekVBI Vaccines (VBIV) Announces Late-Breaker Cytomegalovirus Abstract Chosen for Oral Presentation at IDWeek
www.streetinsider.com - October 3 at 8:47 AM
VBI Vaccines’ Late-Breaker Cytomegalovirus Abstract Chosen for Oral Presentation at IDWeek 2018VBI Vaccines’ Late-Breaker Cytomegalovirus Abstract Chosen for Oral Presentation at IDWeek 2018
finance.yahoo.com - October 2 at 8:50 AM
VBI Vaccines to Present at the Ladenburg Thalmann 2018 Healthcare ConferenceVBI Vaccines to Present at the Ladenburg Thalmann 2018 Healthcare Conference
finance.yahoo.com - September 27 at 9:11 AM
VBI Vaccines Announces Formation of New Scientific and Clinical Advisory BoardsVBI Vaccines Announces Formation of New Scientific and Clinical Advisory Boards
finance.yahoo.com - September 26 at 9:16 AM
VBI Vaccines (VBIV) Reports Second Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) PatientsVBI Vaccines (VBIV) Reports Second Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients
www.streetinsider.com - September 25 at 8:43 AM
VBI Vaccines Announces Second Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) PatientsVBI Vaccines Announces Second Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients
finance.yahoo.com - September 25 at 8:43 AM
VBI Vaccines takes issue with critical news articleVBI Vaccines takes issue with critical news article
seekingalpha.com - September 17 at 9:15 AM
Join Perceptive Advisors And Buy VBI Vaccines At $2 NowJoin Perceptive Advisors And Buy VBI Vaccines At $2 Now
seekingalpha.com - September 10 at 10:11 AM
New finance chief at VBI VaccinesNew finance chief at VBI Vaccines
seekingalpha.com - August 15 at 4:44 PM
VBI Vaccines Appoints Christopher McNulty as Chief Financial Officer and Head of Business DevelopmentVBI Vaccines Appoints Christopher McNulty as Chief Financial Officer and Head of Business Development
finance.yahoo.com - August 15 at 9:08 AM
VBI Vaccines to Present at the Canaccord Genuity 38th Annual Growth ConferenceVBI Vaccines to Present at the Canaccord Genuity 38th Annual Growth Conference
finance.yahoo.com - August 6 at 4:46 PM
VBI Vaccines Announces Second Quarter 2018 Financial Results and Provides Corporate UpdateVBI Vaccines Announces Second Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - July 26 at 9:17 AM
VBI Vaccines to Participate in the 2018 Oppenheimer Boston Oncology Insight SummitVBI Vaccines to Participate in the 2018 Oppenheimer Boston Oncology Insight Summit
finance.yahoo.com - July 9 at 8:52 AM
VBI Vaccines to Present at 2018 JMP Securities Life Sciences ConferenceVBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference
finance.yahoo.com - June 19 at 10:58 AM
Reader Inquiry: VBI Vaccines´ CEO Is Buying Shares, Should You?Reader Inquiry: VBI Vaccines´ CEO Is Buying Shares, Should You?
seekingalpha.com - May 27 at 9:02 AM
VBI Vaccines Announces Results of Annual General MeetingVBI Vaccines Announces Results of Annual General Meeting
finance.yahoo.com - May 25 at 4:43 PM
Health Care Sector Update for 05/22/2018: VBIV,CTMX,RDY,BMRNHealth Care Sector Update for 05/22/2018: VBIV,CTMX,RDY,BMRN
www.nasdaq.com - May 23 at 4:41 PM
VBI Vaccines (VBIV) Outlines Clinical Trial ProgressVBI Vaccines (VBIV) Outlines Clinical Trial Progress
www.streetinsider.com - May 22 at 4:43 PM
Well Leveraged: VBI Vaccines Outlines Clinical Trial ProgressWell Leveraged: VBI Vaccines Outlines Clinical Trial Progress
finance.yahoo.com - May 22 at 4:43 PM
VBI Vaccines (VBIV) CMV Vaccine VBI - 1501A Final Phase I Data - SlideshowVBI Vaccines (VBIV) CMV Vaccine VBI - 1501A Final Phase I Data - Slideshow
seekingalpha.com - May 11 at 4:52 PM
UPDATE: VBI Vaccines (VBIV) PT Raised to $13 at BMO CapitalUPDATE: VBI Vaccines (VBIV) PT Raised to $13 at BMO Capital
www.streetinsider.com - May 10 at 4:43 PM
VBI Vaccines (VBIV) Reports Positive Final Phase 1 Study Results of Preventative CMV VaccineVBI Vaccines (VBIV) Reports Positive Final Phase 1 Study Results of Preventative CMV Vaccine
www.streetinsider.com - May 10 at 4:43 PM
VBIs CMV vaccine candidate shows positive effect in early-stage study; shares ahead 11% premarketVBI's CMV vaccine candidate shows positive effect in early-stage study; shares ahead 11% premarket
seekingalpha.com - May 10 at 9:27 AM
VBI Vaccines misses by $0.03VBI Vaccines misses by $0.03
seekingalpha.com - May 1 at 9:07 AM
VBI Vaccines Announces First Quarter 2018 Financial Results and Provides Corporate UpdateVBI Vaccines Announces First Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - May 1 at 9:07 AM
BRIEF-VBI Vaccines Announces Completion Of Enrollment In Protect Phase 3 Clinical Study For Sci-B-Vac Hepatitis B ...BRIEF-VBI Vaccines Announces Completion Of Enrollment In Protect Phase 3 Clinical Study For Sci-B-Vac Hepatitis B ...
www.reuters.com - April 21 at 9:01 AM
VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B ...VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B ...
globenewswire.com - April 21 at 9:01 AM
VBI Vaccines completes enrollment in late-stage study of Sci-B-VacVBI Vaccines completes enrollment in late-stage study of Sci-B-Vac
seekingalpha.com - April 19 at 4:49 PM
VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B VaccineVBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B Vaccine
finance.yahoo.com - April 19 at 9:31 AM
BRIEF-VBI Vaccines Posts Positive DSMB Review Of Recurrent Glioblastoma StudyBRIEF-VBI Vaccines Posts Positive DSMB Review Of Recurrent Glioblastoma Study
www.reuters.com - April 17 at 4:46 PM
VBI Vaccines (VBIV) Reports Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent GBM PatientsVBI Vaccines (VBIV) Reports Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent GBM Patients
www.streetinsider.com - April 17 at 4:46 PM
VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) PatientsVBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients
finance.yahoo.com - April 17 at 9:21 AM
ICYMI: Penny Stocks, Energy ETF, AR And VR DevicesICYMI: Penny Stocks, Energy ETF, AR And VR Devices
finance.yahoo.com - March 16 at 10:03 AM
VBI Vaccines Announces Voluntary Delisting from the Toronto Stock ExchangeVBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange
finance.yahoo.com - March 12 at 4:44 PM
VBI Vaccines (VBIV) Announces Exit of Sam Chawla and Ran Nussbaum from Board - StreetInsider.comVBI Vaccines (VBIV) Announces Exit of Sam Chawla and Ran Nussbaum from Board - StreetInsider.com
www.streetinsider.com - January 27 at 6:34 AM
VBI Vaccines (VBIV) Reports Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901VBI Vaccines (VBIV) Reports Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901
www.streetinsider.com - January 18 at 3:55 PM
VBI Vaccines (VBIV) Reports Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901 - StreetInsider.comVBI Vaccines (VBIV) Reports Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901 - StreetInsider.com
www.streetinsider.com - January 18 at 11:37 AM
VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901
finance.yahoo.com - January 17 at 10:24 AM
ETFs with exposure to VBI Vaccines, Inc. : December 26, 2017ETFs with exposure to VBI Vaccines, Inc. : December 26, 2017
finance.yahoo.com - December 26 at 8:34 PM
VBI Vaccines, Inc. :VBIV-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017VBI Vaccines, Inc. :VBIV-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
finance.yahoo.com - December 25 at 5:47 PM
This page was last updated on 12/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel